TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 22118569

Group type: COMPARATOR
Intervention: Control (wheat-fiber, n = 74)
Number of subjects: 367

Group type: EXPERIMENTAL
Intervention: 3 g high-MW oat β-glucan (3H, n = 67)
Number of subjects: 367

Group type: EXPERIMENTAL
Intervention: 4 g medium-MW oat β-glucan (4M, n = 50)
Number of subjects: 367

Group type: EXPERIMENTAL
Intervention: 3 g medium-MW oat β-glucan (3M, n = 54)
Number of subjects: 367

Group type: EXPERIMENTAL
Intervention: 4 g low-MW oat β-glucan (4L, n = 51)
Number of subjects: 367
Study: 19797553

Group type: EXPERIMENTAL
Intervention: Toothbrushing
Number of subjects: 194

Group type: COMPARATOR
Intervention: Single-tooth extraction with placebo
Number of subjects: 194
Study: 17022023

Group type: EXPERIMENTAL
Intervention: History of infertility (physician diagnosis, prescription for infertility medication, or evaluation at infertility clinics)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Prescription of clomiphene citrate within 60 days before to 15 days after conception
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (no history of infertility)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (no prescription of clomiphene citrate)
Number of subjects: 18
Study: 15163330

Group type: EXPERIMENTAL
Intervention: Nutritional programme (12 mg/day iron and 6000 IU/week vitamin A)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Oxandrolone therapy (5 mg/day for 6 months)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Testosterone depot (100 mg monthly for 3 months or 6 months)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Passive observation
Number of subjects: 102
Study: 11343496

Group type: EXPERIMENTAL
Intervention: Supplementary structured breastfeeding counseling (SSBC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional hospital breastfeeding support (CHBS)
Number of subjects: 0
Study: 9404208

Group type: EXPERIMENTAL
Intervention: AUTOKV mode (automatic kV selection)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fixed kV of 28
Number of subjects: 0
Study: 8093915

Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin (LMWH)
Number of subjects: 3809

Group type: COMPARATOR
Intervention: Standard heparin (SH)
Number of subjects: 3809
Study: 2889306

Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous infusion of SMS 201-995 (50 micrograms and 100 micrograms a day)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous infusion of SMS 201-995 (100 micrograms)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous infusion of SMS 201-995
Number of subjects: 7

Group type: COMPARATOR
Intervention: Multiple subcutaneous injections of SMS 201-995 (100 micrograms each)
Number of subjects: 7
Study: 29771337

Group type: EXPERIMENTAL
Intervention: SCP+PCP (Survivorship Care Plans taken to Primary Care Physician)
Number of subjects: 96

Group type: COMPARATOR
Intervention: SC (Survivorship Clinic)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: SCP+PCP
Number of subjects: 96

Group type: COMPARATOR
Intervention: SC
Number of subjects: 96
Study: 27351628

Group type: EXPERIMENTAL
Intervention: Everolimus (4.5 mg/m2/day, titrated to a target blood trough of 5-15 ng/mL)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Everolimus
Number of subjects: 111
Study: 24100337

Group type: EXPERIMENTAL
Intervention: HES 130/0.4
Number of subjects: 40

Group type: COMPARATOR
Intervention: Lactated Ringer's solution
Number of subjects: 40
Study: 22715833

Group type: EXPERIMENTAL
Intervention: Cold air application
Number of subjects: 40

Group type: COMPARATOR
Intervention: No cold air application
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Cold air application in palm injections
Number of subjects: 40
Study: 20501394

Group type: EXPERIMENTAL
Intervention: BUMA drug-eluting stent
Number of subjects: 22

Group type: COMPARATOR
Intervention: Endeavor drug-eluting stent
Number of subjects: 22
Study: 18703460

Group type: EXPERIMENTAL
Intervention: 4-session female condom skills training intervention
Number of subjects: 409

Group type: COMPARATOR
Intervention: 4-session women's general health promotion intervention
Number of subjects: 409
Study: 15852992

Group type: EXPERIMENTAL
Intervention: 10 mg metoclopramide
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 20 mg metoclopramide
Number of subjects: 45

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 45
Study: 11863320

Group type: EXPERIMENTAL
Intervention: ondansetron 8 mg
Number of subjects: 60

Group type: COMPARATOR
Intervention: ondansetron 4 mg
Number of subjects: 60
Study: 9771858

Group type: EXPERIMENTAL
Intervention: High nonstarch polysaccharide (NSP) diet
Number of subjects: 12

Group type: COMPARATOR
Intervention: Usual mixed diet
Number of subjects: 12
Study: 7826816

Group type: EXPERIMENTAL
Intervention: CRC patients
Number of subjects: 185

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 185
Study: 3063436

Group type: EXPERIMENTAL
Intervention: 20 mg sodium hyaluronate
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study: 30077383

Group type: EXPERIMENTAL
Intervention: Immediate implant placement with ultra-wide 7-mm-diameter implants
Number of subjects: 0

Group type: COMPARATOR
Intervention: Delayed implant placement in molar healed sites after socket preservation
Number of subjects: 0
Study: 27068423

Group type: EXPERIMENTAL
Intervention: Submucosal inferior turbinoplasty
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Radiofrequency cauterization
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (healthy adults)
Number of subjects: 60
Study: 23899952

Group type: EXPERIMENTAL
Intervention: Multifactorial memory training program
Number of subjects: 51

Group type: COMPARATOR
Intervention: Active control group (discussing different psychological issues)
Number of subjects: 51
Study: 21492416

Group type: EXPERIMENTAL
Intervention: Azithromycin (30 mg/kg/dose) administered once weekly for three doses
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo administered once weekly for three doses
Number of subjects: 200
Study: 16409560

Group type: EXPERIMENTAL
Intervention: Low-carbohydrate (LC) dietary advice
Number of subjects: 102

Group type: COMPARATOR
Intervention: Reduced-portion, low-fat dietary advice (Control)
Number of subjects: 102
Study: 15232360

Group type: EXPERIMENTAL
Intervention: Parecoxib sodium 40 mg twice daily for 7 days
Number of subjects: 123

Group type: COMPARATOR
Intervention: Placebo for 7 days
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Ketorolac 30 mg 4 times daily for 5 days
Number of subjects: 123
Study: 11720831

Group type: EXPERIMENTAL
Intervention: Urokinase (5000 units)
Number of subjects: 100
Study: 9480237

Group type: EXPERIMENTAL
Intervention: Spontaneous delivery
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Oxytocin induced delivery
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Cesarean section
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control (beta 2-microglobulin)
Number of subjects: 50
Study: 8201970

Group type: EXPERIMENTAL
Intervention: Theophylline (IV bolus of 220 mg followed by IV infusion of 1 mg/kg/h)
Number of subjects: 20

Group type: COMPARATOR
Intervention: NaCl (control)
Number of subjects: 20
Study: 3354399

Group type: EXPERIMENTAL
Intervention: Thrombolytic therapy (230 patients)
Number of subjects: 448

Group type: COMPARATOR
Intervention: Conventional therapy (218 patients)
Number of subjects: 448
Study: 31218819

Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg once daily for 12 weeks
Number of subjects: 300

Group type: COMPARATOR
Intervention: Placebo once daily for 12 weeks
Number of subjects: 300
Study: 28337686

Group type: COMPARATOR
Intervention: Knowledge only
Number of subjects: 255

Group type: COMPARATOR
Intervention: Skills only
Number of subjects: 255

Group type: COMPARATOR
Intervention: Combined knowledge and skills (TBSI)
Number of subjects: 255

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 255
Study: 25596158

Group type: EXPERIMENTAL
Intervention: Brace
Number of subjects: 126

Group type: COMPARATOR
Intervention: Control
Number of subjects: 126
Study: 23318399

Group type: EXPERIMENTAL
Intervention: Experimental group (n=361 patients after intervention)
Number of subjects: 826

Group type: COMPARATOR
Intervention: Control group (n=389 patients after intervention)
Number of subjects: 826

Group type: EXPERIMENTAL
Intervention: Experimental group (n=402 patients before intervention)
Number of subjects: 826

Group type: COMPARATOR
Intervention: Control group (n=424 patients before intervention)
Number of subjects: 826
Study: 21199268

Group type: EXPERIMENTAL
Intervention: Sitagliptin 100 mg daily
Number of subjects: 1035

Group type: COMPARATOR
Intervention: Glimepiride (starting dose 1 mg/day, max 6 mg/day)
Number of subjects: 1035
Study: 19081901

Group type: EXPERIMENTAL
Intervention: Strontium chloride (SR)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 142
Study: 22313587

Group type: EXPERIMENTAL
Intervention: DHA (C22)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Oleic acid (OA)
Number of subjects: 18

Group type: COMPARATOR
Intervention: No treatment (NT)
Number of subjects: 18
Study: 16713501

Group type: EXPERIMENTAL
Intervention: Alcohol administration study with feedback and information about harmful effects
Number of subjects: 59

Group type: COMPARATOR
Intervention: Alcohol administration study
Number of subjects: 59
Study: 12898439

Group type: COMPARATOR
Intervention: intermittent subcutaneous IL-2 and placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: intermittent subcutaneous IL-2 and prednisone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: intermittent prednisone
Number of subjects: 0

Group type: COMPARATOR
Intervention: intermittent placebo
Number of subjects: 0
Study: 10371876

Group type: EXPERIMENTAL
Intervention: Zinc citrate dentifrice (2% zinc citrate and 0.76% sodium monofluorophosphate in a silica base)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Control dentifrice (0.76% sodium monofluorophosphate in a silica base)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Zinc citrate dentifrice
Number of subjects: 99

Group type: COMPARATOR
Intervention: Control dentifrice
Number of subjects: 99
Study: 7602215

Group type: EXPERIMENTAL
Intervention: MDT + BCG (rifampin once a month, clofazimine and dapsone daily, BCG intradermally 0.1 mg/dose)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: MDT + Mycobacterium w (same MDT with 2 x 10(8) killed bacilli/dose i.d.)
Number of subjects: 36

Group type: COMPARATOR
Intervention: MDT alone (control group)
Number of subjects: 36
Study: 2772038

Group type: EXPERIMENTAL
Intervention: NO-VAL Group
Number of subjects: 27

Group type: COMPARATOR
Intervention: CONT Group
Number of subjects: 27
Study: 799927

Group type: EXPERIMENTAL
Intervention: Antihypertensive therapy
Number of subjects: 4000

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 4000
Study: 31009801

Group type: EXPERIMENTAL
Intervention: Inertial measurement units (IMUs)
Number of subjects: 26
Study: 31864519

Group type: EXPERIMENTAL
Intervention: Individualized rehabilitation and chiropractic treatment
Number of subjects: 13

Group type: COMPARATOR
Intervention: Individualized rehabilitation alone
Number of subjects: 13
Study: 28731004

Group type: EXPERIMENTAL
Intervention: Early goal-directed mobilization using the Surgical Optimal Mobilization Score (SOMS) algorithm.
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Early goal-directed mobilization protocol.
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group mobilization according to individual centre’s standard protocols.
Number of subjects: 200
Study: 25343537

Group type: EXPERIMENTAL
Intervention: Heated water-based exercise (HEx)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Land-based exercise (LEx)
Number of subjects: 15
Study: 23516146

Group type: EXPERIMENTAL
Intervention: Behavioural-educational sleep intervention
Number of subjects: 246

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 246
Study: 22093629

Group type: EXPERIMENTAL
Intervention: Paclitaxel combined with platinum
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Paclitaxel liposome combined with platinum
Number of subjects: 162
Study: 18641526

Group type: EXPERIMENTAL
Intervention: Debridement twice a week (Group 1)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Debridement once a week (Group 2)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Debridement once every 2 weeks (Group 3)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (no specific intervention mentioned)
Number of subjects: 30
Study: 16875473

Group type: EXPERIMENTAL
Intervention: TAC (10 mg/mL) injected weekly for 8 weeks
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: TAC (40 mg/mL) + 5-FU (50 mg/mL) injected weekly for 8 weeks
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: TAC (40 mg/mL) + 5-FU (50 mg/mL) injected weekly for 8 weeks + PDL (5-7.5 J/cm2) at 1st, 4th, and 8th weeks
Number of subjects: 69
Study: 12621503

Group type: EXPERIMENTAL
Intervention: Peripheral blood stem cells (PBSC)
Number of subjects: 213

Group type: COMPARATOR
Intervention: Bone marrow (BM)
Number of subjects: 213
Study: 10718774

Group type: EXPERIMENTAL
Intervention: 10 mg, 20 mg, and 10 + 20 mg tablets; solution administered once daily for 2 weeks
Number of subjects: 26

Group type: COMPARATOR
Intervention: Tablets
Number of subjects: 26

Group type: COMPARATOR
Intervention: Solution
Number of subjects: 26
Study: 8653389

Group type: EXPERIMENTAL
Intervention: Audible speech
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Silent speech (internal speech)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Rest
Number of subjects: 30
Study: 1327051

Group type: EXPERIMENTAL
Intervention: Ramipril (10 mg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 3855338

Group type: EXPERIMENTAL
Intervention: Argon laser trabeculoplasty
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Surgical trabeculectomy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Medicine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Laser
Number of subjects: 0
Study: 29291550

Group type: EXPERIMENTAL
Intervention: EtG screening
Number of subjects: 162

Group type: COMPARATOR
Intervention: Ethanol screening
Number of subjects: 162
Study: 28453765

Group type: EXPERIMENTAL
Intervention: mongersen (Smad7 antisense oligonucleotide)
Number of subjects: 95

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Smad7 over-expressing NCM460 cells
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: TGF-β1
Number of subjects: 95
Study: 26641456

Group type: EXPERIMENTAL
Intervention: Resistive vibration exercise countermeasure during 8 weeks of bed rest
Number of subjects: 20

Group type: COMPARATOR
Intervention: Strict bed rest without exercise
Number of subjects: 20
Study: 22971113

Group type: EXPERIMENTAL
Intervention: Peer health worker (PHW) intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: mHealth (mobile phone) support intervention
Number of subjects: 0
Study: 20970870

Group type: EXPERIMENTAL
Intervention: Insulin glargine
Number of subjects: 0

Group type: COMPARATOR
Intervention: NPH
Number of subjects: 0
Study: 18468323

Group type: EXPERIMENTAL
Intervention: Zinc phosphate cement on untreated zirconia copings
Number of subjects: 140

Group type: COMPARATOR
Intervention: Sandblasted zirconia copings
Number of subjects: 140

Group type: COMPARATOR
Intervention: Untreated alumina copings
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Glass pearls on zirconia copings
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Variolink II with alumina copings
Number of subjects: 140
Study: 16563204

Group type: EXPERIMENTAL
Intervention: Brief Core Schema Scales (BCSS)
Number of subjects: 1006

Group type: EXPERIMENTAL
Intervention: BCSS
Number of subjects: 1006
Study: 14584871

Group type: EXPERIMENTAL
Intervention: One-stage full-mouth scaling and root planing (FMSRP) plus amoxicillin/clavulanic acid 875 mg (G1)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Only FMSRP (G2)
Number of subjects: 30
Study: 11469284

Group type: EXPERIMENTAL
Intervention: Early occupational therapy intervention, given weekly at home from six months to 12 months.
Number of subjects: 100

Group type: COMPARATOR
Intervention: Non-intervention (control) group.
Number of subjects: 100
Study: 10211012

Group type: EXPERIMENTAL
Intervention: Tenoxicam 40 mg
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Tenoxicam 20 mg
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 7948562

Group type: EXPERIMENTAL
Intervention: Rifabutin (600 mg/d)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 3252772

Group type: EXPERIMENTAL
Intervention: Students (intervention group)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Children and elderly (control group)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Temperature of water at 37 degrees C
Number of subjects: 44

Group type: COMPARATOR
Intervention: Surface anaesthesia of tongue and palate
Number of subjects: 44

Group type: COMPARATOR
Intervention: Sipping vs. gulping
Number of subjects: 44

Group type: COMPARATOR
Intervention: Time taken for water to enter the mouth
Number of subjects: 44
Study: 31981517

Group type: EXPERIMENTAL
Intervention: Colonoscopy with CADe system
Number of subjects: 962

Group type: COMPARATOR
Intervention: Colonoscopy with sham system
Number of subjects: 962
Study: 29528792

Group type: EXPERIMENTAL
Intervention: Selumetinib (75 mg twice daily) plus dacarbazine (1,000 mg/m2 intravenously on day 1 of every 21-day cycle)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Placebo plus dacarbazine (1,000 mg/m2 intravenously on day 1 of every 21-day cycle)
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Selumetinib plus dacarbazine
Number of subjects: 129

Group type: COMPARATOR
Intervention: Placebo plus dacarbazine
Number of subjects: 129
Study: 28126333

Group type: EXPERIMENTAL
Intervention: Ceritinib 750 mg/day
Number of subjects: 376

Group type: COMPARATOR
Intervention: Platinum-based chemotherapy (cisplatin 75 mg/m2 or carboplatin AUC 5-6 plus pemetrexed 500 mg/m2 every 3 weeks for four cycles followed by maintenance pemetrexed)
Number of subjects: 376
Study: 26432173

Group type: EXPERIMENTAL
Intervention: Cognitive Behavior Therapy (CBT)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Interpersonal Psychotherapy (IPT)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Therapy process at the end stage
Number of subjects: 165
Study: 23239676

Group type: EXPERIMENTAL
Intervention: Beta-alanine (80 mg · kg‐1 BM · d‐1)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo (glucose)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Beta-alanine
Number of subjects: 16

Group type: COMPARATOR
Intervention: Beta-alanine and Placebo
Number of subjects: 16
Study: 21623838

Group type: EXPERIMENTAL
Intervention: Haptic VR simulator training using microcomputed tomography tooth models
Number of subjects: 32

Group type: COMPARATOR
Intervention: Conventional training using extracted teeth in a phantom head
Number of subjects: 32
Study: 18287411

Group type: EXPERIMENTAL
Intervention: Percutaneous ethanol injection (PEI) + radiofrequency ablation (n = 50)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Radiofrequency ablation alone (n = 114)
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: High-risk radiofrequency ablation (n = 50)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Radiofrequency ablation of non-high-risk tumors (n = 44)
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: High-risk radiofrequency ablation + PEI (n = 50)
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Patients with high-risk tumors
Number of subjects: 142

Group type: COMPARATOR
Intervention: Patients without high-risk tumors
Number of subjects: 142
Study: 16541860

Group type: EXPERIMENTAL
Intervention: Penetration needling (Yintang (EX‐HN 3)‐through‐Bigen, Sibai (ST 2)‐through‐Bigen, Yingxiang (LI 20)‐through‐Bigen)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Oral Biyankang, 4 tablets each time, 3 times daily
Number of subjects: 120
Study: 12506149

Group type: EXPERIMENTAL
Intervention: Polysporin Triple antibiotic ointment
Number of subjects: 169

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 169
Study: 10503691

Group type: EXPERIMENTAL
Intervention: Formula containing 0.32‐1.1% AA and 0.24‐0.75% DHA
Number of subjects: 4

Group type: COMPARATOR
Intervention: Formula without AA and DHA (Preemie SMA)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Breast milk with fortifier
Number of subjects: 4
Study: 8944697

Group type: EXPERIMENTAL
Intervention: Telenzepine (selective M1-receptor antagonist)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 2021851

Group type: EXPERIMENTAL
Intervention: Suturing
Number of subjects: 1004

Group type: EXPERIMENTAL
Intervention: Stapling
Number of subjects: 1004
Study: 6758743

Group type: EXPERIMENTAL
Intervention: Labetalol (twice daily dosage)
Number of subjects: 10
Study: 31301436

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 60
Study: 28355960

Group type: EXPERIMENTAL
Intervention: Multidomain intervention
Number of subjects: 202

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 202
Study: 26299215

Group type: EXPERIMENTAL
Intervention: AUC‐based educational and feedback intervention including a lecture, access to a mobile app, and individualized feedback reports.
Number of subjects: 0

Group type: COMPARATOR
Intervention: No education on TTE appropriate use (usual practice).
Number of subjects: 0
Study: 24075621

Group type: EXPERIMENTAL
Intervention: Abiraterone plus prednisone
Number of subjects: 1088

Group type: COMPARATOR
Intervention: Placebo plus prednisone
Number of subjects: 1088
Study: 21417810

Group type: EXPERIMENTAL
Intervention: YPET (yogic prana energization technique)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (conventional plaster of paris immobilization)
Number of subjects: 30
Study: 19104413

Group type: EXPERIMENTAL
Intervention: ALG-induction, CsA, and prednisone
Number of subjects: 123

Group type: COMPARATOR
Intervention: CsA, prednisone, and azathioprine
Number of subjects: 123
Study: 16579257

Group type: EXPERIMENTAL
Intervention: Unrestricted weightbearing (UWB) combined with intensive physiotherapy
Number of subjects: 36

Group type: COMPARATOR
Intervention: Partial weightbearing (PWB) for 3 months combined with a short self‐training program
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 36
Study: 12929017

Group type: EXPERIMENTAL
Intervention: Pancreatic duct guide wire placement
Number of subjects: 53

Group type: COMPARATOR
Intervention: Conventional catheter
Number of subjects: 53